Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
 
Perspective
No 'safe' level of HCP sponsorship
Australian pharma has made considerable concessions in recent years to prove it has nothing to hide in doctor education payments but is it worth the pain if it fails to silence the critics?
Approvals Action
New AbbVie, Sanofi therapies kick off 2018
AbbVie and Sanofi have both seen new products registered on the ARTG over the past month while generic companies have made moves on older therapies.
Special Report
PBAC March agenda in full
The PBAC will consider 63 submissions at its March meeting, although the number of major submissions has been dialled back when compared to its bumper meet-up of last month.